|10/14/16||OraSure Technologies Announces 2017 Annual Meeting Date|
|BETHLEHEM, Pa., Oct. 14, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2017 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 16, 2017. This will be a completely virtual meeting, conducted as a live webcast. Further details regarding the meeting will be provided at a later date.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of ... |
|10/12/16||OraSure Technologies Earnings Conference Call Invitation|
|2016 Third Quarter Earnings Conference Call Wednesday, November 2, 2016, 5:00 p.m. ET
BETHLEHEM, Pa., Oct. 12, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 third quarter financial results, 2016 fourth quarter financial guidance, and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 2, 2016.
November 2, 2016 Schedule
4:00 p.m. ET
2016 third quarter fina... |
|09/06/16||OraSure Technologies to Present at the CL King 14th Annual Best Ideas Conference|
|BETHLEHEM, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the CL King 14th Annual Best Ideas Conference in New York. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on September 13, 2016, at approximately 10:15 AM Eastern Time (7:1... |
|08/29/16||DNA Genotek’s OMNIgene® GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome|
|Human Longevity Inc. Study on OMNIgene® GUT Recently Published in Scientific Reports
BETHLEHEM, Pa., Aug. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that a study conducted by Human Longevity, Inc. (HLI) and published in the Journal Scientific Reports (Nature Publishing Group) on August 25, 2016 proposes the use of the OMNIgene•GUT microbiome sample collection and stabilization device sold by OraSure’s wholly-owned subsidiary, DNA Genotek Inc., in gl... |